Compare WETH & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WETH | BFRI |
|---|---|---|
| Founded | 1992 | 1997 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7M | 16.3M |
| IPO Year | 2020 | 2021 |
| Metric | WETH | BFRI |
|---|---|---|
| Price | $1.09 | $1.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 134.8K | ★ 333.6K |
| Earning Date | 04-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.38 | ★ 67.70 |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $45,136,818.00 | $41,705,000.00 |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | $3.16 | ★ N/A |
| Revenue Growth | 6.76 | ★ 11.75 |
| 52 Week Low | $0.82 | $0.57 |
| 52 Week High | $3.68 | $1.27 |
| Indicator | WETH | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 43.99 | 54.67 |
| Support Level | $0.95 | $0.73 |
| Resistance Level | $1.49 | N/A |
| Average True Range (ATR) | 0.12 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 29.18 | 67.27 |
Wetouch Technology Inc is a business of research and development, manufacturing, and distribution of touchscreen displays to customers both in the PRC and overseas. The touchscreen products, which are manufactured by the Company, are mainly for use in financial terminals, automotive, Point of Sales, gaming, lottery, medical, Human-Machine Interface (HMI), and other specialized industries. The company sells touchscreen products both domestically in China and internationally, covering areas in Mainland China, including but not limited to the eastern, southern, northern, and southwest regions of Mainland China, Taiwan, South Korea, Germany, and other countries.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.